Latest News

Dr. Hal Broxmeyer, Ph.D., a pioneer in the field of cord blood transplantation passed away on December 8, 2021 due to thyroid cancer. CCBC recognizes the work and legacy of Dr. Broxmeyer, whose research was instrumental in developing the field [...]

2022 was a year of focused professional development and awards of certification for CCBC Quality Manager Dawn Thut, CABP.  Dawn successfully completed the Regulatory Affairs Certificate Program for Pharmaceuticals offered by the Regulatory Affairs Professionals Society (RAPS).  In addition, Dawn [...]

In 2022, CCBC achieved a significant milestone within its organization and for the donors and survivors it serves. CCBC celebrated its 10 year anniversary collecting cord blood donations in Atlanta from its Piedmont Hospital and Emory University Hospital Midtown [...]

The Cleveland Cord Blood Center’s (CCBC’s) Wound Healing Project has launched into its next phase of exploration. Through the wound healing project, the research team is investigating how umbilical cord blood monocytes and platelet rich plasma may prove helpful in [...]

Over the course of the past two years, the Cleveland Cord Blood Center (CCBC) has realized meaningful growth in virtually every aspect of our organization. This growth did not happen overnight. Rather, it is the result of our long-term strategy [...]

Deverra Therapeutics, Inc., a leading clinical-stage company developing therapeutic allogeneic off-the-shelf cord-blood derived therapeutics has entered into a manufacturing service agreement with the Cleveland Cell Therapy Incubator (CCTI), a subsidiary of the Cleveland Cord Blood Center. For CCTI, this is [...]

In 2021, research scientists of the Cleveland Cord Blood Center’s Research & Development Laboratory conducted proof-of-concept research in the development of umbilical cord-derived stem cell treatments to address unmet medical needs. Research projects explored treatments for patients with Parkinson’s disease, [...]

Need for CORD BLOOD DIVERSITY compels organizational response. A donor search for a bone marrow transplant needed by a Caucasian patient has a 77 percent likelihood of finding a match while a similar search on behalf of an African American [...]

“We had collected cord blood units for private banks but never on a large scale prior to our relationship with the Cleveland Cord Blood Center. What a great partnership,” said Michelle Gebhardt, M.D., OBGYN Practitioner at the Kaiser Permanente San [...]

The Cleveland Cord Blood Center (CCBC) is in the midst of one of the most exciting times in our history! We can truly say that we’re pursuing new opportunities reflective of our mission at a pace that we could never [...]

Glycostem Therapeutics B.V., a leading clinical-stage company focused on the development of therapeutic allogeneic off-the-shelf Natural Killer (NK) cells, has entered into an agreement with Cleveland Cord Blood Center’s state-of-the-art Cleveland Cell Therapy Incubator (CCTI). CCTI is a wholly owned [...]

This October, Satyabrata Sinha, Ph.D., joined Cleveland Cord Blood Center’s research staff to lead CCBC’s continued exploration of cord-blood derived stem cell therapy for the treatment of Parkinson’s disease. Sinha has a strong research background with a Ph.D. focused on [...]

Cleveland Cord Blood Center’s newest collection site at the Kaiser Permanente San Leandro Medical Center was selected to enhance the diversity of the CCBC cord blood inventory. From its launch in June 2021 through the end of September 2021, 68 [...]